2010
DOI: 10.1176/ps.2010.61.9.865
|View full text |Cite
|
Sign up to set email alerts
|

Best Practices: Disseminating Best Practices for Bipolar Disorder Treatment in a Correctional Population

Abstract: Use of medication treatment algorithms may facilitate clinical decision making, improve consistency, and reduce polypharmacy in the correctional setting. A feasibility study was conducted investigating use of Texas Implementation of Medication Algorithms (TIMA) guidelines for bipolar disorder in the Connecticut Department of Correction. Forty inmates with diagnoses of bipolar disorder were treated over a 12-week period adhering to the TIMA algorithm for bipolar disorder. Significant improvement was seen in the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
5
0

Year Published

2011
2011
2024
2024

Publication Types

Select...
7

Relationship

3
4

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 11 publications
0
5
0
Order By: Relevance
“…Our knowledge is relatively limited even with respect to the practice of polypharmacy in BD inmates. Two longitudinal 12-week studies by Kamath et al documented strikingly high prevalence rates for polypharmacy (use of three or more psychotropic medications at one) in 84% of the cases (out of a total sample of 40 BD-I or BD-II cases, equal ratios for males and females) 43 urging the need for standard medication algorithms to reduce the polypharmacy in the correctional setting, with a special reference to antidepressant and antipsychotic drugs. 70 Similarly, despite the acknowledgment that pharmacological treatments for BD have historically been associated with neurocognitive side effects, especially in elderly subjects or otherwise possibly cognitively vulnerable subjects who would be particularly sensitive to polypharmacy, 71 , 72 very little is known about these subjects, including bipolar subjects with intellectual disabilities (IDs).…”
Section: Resultsmentioning
confidence: 99%
“…Our knowledge is relatively limited even with respect to the practice of polypharmacy in BD inmates. Two longitudinal 12-week studies by Kamath et al documented strikingly high prevalence rates for polypharmacy (use of three or more psychotropic medications at one) in 84% of the cases (out of a total sample of 40 BD-I or BD-II cases, equal ratios for males and females) 43 urging the need for standard medication algorithms to reduce the polypharmacy in the correctional setting, with a special reference to antidepressant and antipsychotic drugs. 70 Similarly, despite the acknowledgment that pharmacological treatments for BD have historically been associated with neurocognitive side effects, especially in elderly subjects or otherwise possibly cognitively vulnerable subjects who would be particularly sensitive to polypharmacy, 71 , 72 very little is known about these subjects, including bipolar subjects with intellectual disabilities (IDs).…”
Section: Resultsmentioning
confidence: 99%
“…There was a great variation in types of interventions reported in the included studies. These include clinician-delivered individual or group psychotherapy [ 39 , 40 , 45 , 46 ]; group-based module curriculum with components on discharge planning and release safety planning and coping, courtroom behavior, treatment compliance, mental health and substance abuse, anger management and conflict, effective communication skills [ 37 ]; adaptation of evidence-based treatment algorithms to improve clinical outcomes [ 36 ]; citizenship project including peer support, citizenship classes [ 43 ]; intermediate care programs to ease transitions from prison to the community [ 47 ]; a new model of care for broadened triggers for mental health referral [ 33 ]; wraparound case management and peer support services [ 35 ]; art brut therapy [ 42 ]; jail and court based diversion programs [ 41 ]; and mental health court [ 44 ]. All of these interventions were delivered at intercepts 3 and 4 (jail/court-based and during community reentry) in the sequential intercept model (see Table 3 ) [ 48 ].…”
Section: Resultsmentioning
confidence: 99%
“…Due to methodological heterogeneity, not all studies reported effect sizes. However, for those studies that reported effect sizes, the effect sizes ranged from ( p < 0.001) [ 36 ] to ( p < 0.0001) [ 37 ].…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Most existing jail health care studies focus on a single jail or are limited to specific elements of care (e.g., screening) or disease entities (e.g., HIV). [18][19][20][21][22][23] In response, our objective for this study was to generate a comprehensive description of jails' health care structures, resources, and delivery across the entire incarceration experience, from jail entry to release. We undertook this effort in the Southeast, which has some of the highest rates of incarceration of any region in the United States and relatively high levels of community need stemming from low rates of state Medicaid expansion and substantial shortages of community health professionals.…”
mentioning
confidence: 99%